(Photo: The Canadian Press)

By The Canadian Press

Health Canada approves Pfizer antiviral COVID-19 treatment

Jan 17, 2022 | 8:45 AM

OTTAWA, ON – Health Canada has approved Pfizer’s antiviral treatment for COVID-19.

The authorization posted to the Health Canada website Monday morning (January 17) says the treatment is greenlighted for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not authorize it for use on teenagers.

It is also not authorized for use on patients who are already hospitalized because of COVID-19.

Paxlovid is a treatment that uses a combination of drugs to prevent the virus that causes COVID-19 from replicating once it has infected a patient.

Clinical trials show it was almost 90 per cent effective at preventing serious illness in higher-risk patients who received it within the first five days of being infected.

Nighttime construction on Hwy 3 in Lethbridge starts April 17

Apr 17, 2025

SASHA launches #BuyABed fundraiser to support vulnerable Lethbridge residents

Apr 04, 2025

$20K grants available: TELUS STORYHIVE Pan-Asian Edition opens applications April 1

Mar 18, 2025

(The Canadian Press)